+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study



Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study



Digestive Diseases and Sciences 53(2): 399-404



We investigated early postoperative morbidity, mortality, and long-term outcomes in patients with liver cirrhosis (LC) who had undergone curative surgery for gastric cancer. The medical records of patients with LC who had undergone radical gastrectomy for gastric adenocarcinoma between January 1996 and September 2006 were retrospectively reviewed. A total of 57 patients were enrolled in this study. Forty-six patients (81%) were classified into Child's class A. In 22 patients (39%) postoperative complications developed, the most common being ascites (23%), followed by wound infection and hepatic encephalopathy. Postoperative ascites occurred more frequently in patients with Child's class B or C than in those with class A (63.6% vs 13%, P = 0.001). Massive ascites developed in 4 patients, 3 of whom had Child's class B and underwent D2 lymph node (LN) dissection, and 1 of whom had Child's class C and a D1 LN dissection. Postoperative mortality occurred in 5 patients (9%), with a significantly higher mortality rate for patients with Child's class B or C than for those with class A (27.2% vs 4.3%, P = 0.045). With a median follow-up of 32 months, the estimated 5-year survival rate for all patients was 54%. Regardless of the tumor depth, overall survival was longer for patients with Child's class A than for those with Child's class B or C. These results demonstrated that radical gastrectomy with extended LN dissection is feasible in patients with compensated LC. For patients with moderate to severe hepatic dysfunction, however, D1 or less extensive LN dissection may be the more reasonable surgical procedure.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 020731991

Download citation: RISBibTeXText

PMID: 17597403

DOI: 10.1007/s10620-007-9884-3


Related references

Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. Journal of Gastroenterology 52(2): 175-184, 2016

Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Gastric Cancer 15(3): 235-244, 2013

Retrospective study of the recurrent cases who underwent curative gastric resection for gastric cancer. Boei Ika Daigakko Zasshi 13(2): 90-97, 1988

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clinical and Molecular Hepatology 18(4): 368-374, 2013

Robotic, laparoscopic and open surgery for gastric cancer compared on surgical, clinical and oncological outcomes: a multi-institutional chart review. A study protocol of the International study group on Minimally Invasive surgery for GASTRIc Cancer-IMIGASTRIC. Bmj Open 5(10): E008198, 2016

Non-curative surgery for patients with gastric cancer with local peritoneal metastasis: A retrospective cohort study. Medicine 95(49): E5607, 2017

HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. International Journal of Cancer 127(5): 1158-1171, 2010

Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery. Annals of Surgical Oncology 18(4): 1068-1080, 2011

Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study. Biomedicine and PharmacoTherapy 71: 210-215, 2016

Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Digestive Diseases and Sciences 57(6): 1568-1575, 2012

Clinical Significance of Peripheral Blood CEA mRNA Expression in Gastric Cancer Patients Underwent Curative Resection. Cancer Research and Treatment 33(6): 483-488, 2001

Gastric cancer in young patients who underwent curative resection. Comparative study with older patients. American Journal of Clinical Oncology 19(1): 45-48, 1996

Clinical study of early gastric cancer patients who underwent surgical operation after endoscopic mucosal resection (EMR): A report by the committee of endoscopic surgery associated with gastric cancer research. Stomach and Intestine 29(11): 1162-1170, 1994

Surgical strategy for gastric cancer patients with liver cirrhosis: a retrospective cohort study. International Journal of Surgery 12(8): 810-814, 2015

Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2,525 patients who underwent laparoscopy. In Vivo 25(6): 1009-1012, 2012